Journal of Advanced Veterinary and Animal Research · 2021 · 33 citations · 48 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructural BiologyStructure-activity RelationshipsDrug-receptor InteractionsLigand BindingMolecular DockingProtein-ligand InteractionsQuantitative Structure-activity RelationshipsReceptor-ligand InteractionsDocking-based Drug DesignHydrophobic InteractionsLigand PreparationProtein-ligand Complex ModelingProtein-ligand ComplexesSars-cov-2 InfectionStructure-activity Relationship ModelingTarget-ligand Interactions
OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the receptor's active site properties and quantum tunneling. MATERIALS AND METHODS: ), Rg (nm), and polar surface area (PSA) (Å). Finally, computational programming and algorithms were used to interpret the dynamic simulation outputs into their graphical quantitative forms. RESULTS: ), Rg (nm), and PSA (Å) values. CONCLUSION: Considering each of the parameters of molecular optimization, docking, and dynamic simulation interventions, all of the test ligands can be suggested as potential targeted drugs in blocking the hACE2 receptor.
48
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan, Jiwan Ge, Jinfang Yu et al. · Nature · 2020 · 6.7K citations · Full text